One morning last month, Yuan Chang stepped into her office at the University of Pittsburgh School of Medicine and heard some exciting news: The White House called and needed to speak to her.

As she would soon find out, President Barack Obama wanted to appoint her to the National Cancer Advisory Board.

For Dr. Chang, a pathologist with a specialty in cancers caused by viruses, the new job comes with big responsibilities. The National Cancer Advisory Board reviews grant applications from researchers working on related projects and makes recommendations about which of them should receive funding.

It also works with the National Institutes of Health to coordinate the country’s long-term strategy to reduce the prevalence of cancer and the mortality rates associated with it. Meeting at least four times a year, the board’s members, drawn from the ranks of experts in cancer research and public health, serve overlapping terms of six years.

Advertise with us

Dr. Chang will lend her expertise to the board on viral cancers, which lead to 17 percent of cancer cases. Early in her career, she discovered and sequenced the virus that causes Kaposi’s sarcoma, an AIDS-related illness that leaves purple tumor lesions on the skin. At the Pitt School of Medicine’s Cancer Virology Program, she discovered and sequenced the virus behind Merkel cell polyoma, a rare but extremely aggressive skin cancer.

“She’s a distinguished research scientist … and all her expertise makes her qualified to serve on the board,” said Claire Harris, the National Cancer Advisory Board’s committee selection manager.

Dr. Chang, who was born in Taiwan and raised in Utah, said she wanted to go into medicine since childhood.

“I can’t remember a time when I didn’t want to be a doctor,” she said.

She considers herself a visual learner, and for that reason, she was drawn to pathology in medical school.

Advertise with us

“You see a malignant cell under the microscope, and it’s very striking,” she said.

Before arriving at Pitt more than a decade ago, she held academic positions at Stanford and Columbia universities.

Dr. Chang runs her lab at Pitt with her husband, Patrick Moore, an epidemiologist who teaches in the department of microbiology and medical genetics. With his background in epidemiology, which focuses on how disease spreads in a population, and hers in pathology, which looks at how disease manifests in an individual, Dr. Chang believes that the couple make a good research team.

“We’re in two completely different disciplines, and I think it’s really important to have a cross-disciplinary approach,” she said. “We started our research in [Kaposi’s sarcoma] because he knew about the problem due to the AIDS epidemic.”

Dr. Chang’s appointment was cheered by her colleagues.

Advertise with us

“I was thrilled, and not at all surprised,” said Nancy Davidson, director of Pitt’s Cancer Institute. “She’s one of the elites, a giant in the field, and I’m so glad she will be working with leaders in Washington.”

In the next few months, Dr. Chang is looking forward to her first in-person board meeting. She believes it is a promising time in cancer research and that major progress is just around the corner.

“I’m very optimistic. I feel like we are on the cusp of making a great difference in terms of the morbidity and mortality associated with a variety of cancers,” she said.